T. Lüscher in conversation with W. Boden and P. Barter: AIM-HIGH- Extended-Release Niacin Does Not Reduce Clinical Events in Patients with Established Cardiovascular Disease Whose LDL-Cholesterol is Optimally Controlled with Statin Therapy.

T. Lüscher in conversation with S. Goldhaber and M. Cushman: ADOPT- Extended Anticoagulant Prophylaxis in Initially Hospitalized Medically Ill Patients: Results of the ADOPT Trial

T. Lüscher in conversation with K. Mahaffey and K. Fox: TRACER- The Thrombin Receptor Antagonist for Clinical Event Reduction in Acute Coronary Syndrome

T. Lüscher in conversation with A. Hirsh: CLEVER

T. Lüscher in conversation with L. Boersma: FAST- Atrial Fibrillation Catheter Ablation versus Surgical Ablation Treatment.

T. Lüscher in conversation with J. Nielsen and W. Stevenson: MANTRA PAF- A Randomized Multicenter Comparison of Radiofrequency Ablation and Antiarrhythmic Drug Therapy as First-Line Treatment in 294 Patients with Paroxysmal Atrial Fibrillation

B. Gersh in conversation with N. Choudhry and E. Peterson: Post-MI FREEE- The Impact of Full Coverage for Preventive Medications After Myocardial Infarction on Recurrent Vascular Events.

F. Crea in conversation with H. Thiele and A. Jacobs: AIDA STEMI- Intracoronary Compared with Intravenous Bolus Abciximab Application During Primary Percutaneous Coronary Intervention

G. Hindricks in conversation with P. Kowey and C. Tracy: ALPHEE- Double Blind Placebo Controlled Dose Ranging Study of the Efficacy and Safety of Celivarone 50, 100 Or 300 Mg OD with Amiodarone as Calibrator for the Prevention of ICD Interventions or Death

U. Landmesser in conversation with S. Nicholls: SATURN- Comparison of the Progression of Coronary Atherosclerosis for Two High Efficacy Statin Regimens with Different HDL Effects